Cohen-Forterre L, Grigorova-Borsos A M, Falcy C, Mansour G, Mozere G, Peyroux J, Sternberg M
Département de biochimie, Faculté de médecine, Paris, France.
Can J Physiol Pharmacol. 1988 Jul;66(7):884-8. doi: 10.1139/y88-144.
Because kidney microangiopathy with capillary basement membrane thickening has been reported in spontaneous hypertension, we have studied the activities of three lysosomal glycosidases able to degrade the carbohydrate moieties of basement membrane constituents in the kidney cortex of 12-week-old spontaneously hypertensive rats (SHR) and age-matched normotensive Wistar Kyoto rats (WKY). These activities were also determined in SHR and WKY treated from 6 to 12 weeks of age with hydralazine (mean dose, 18 mg/kg per day in drinking water). Sialidase specific activity on sialyl-alpha 2-3-[3H]lactitol was markedly decreased in the kidney of untreated SHR, 40% activity remaining relative to that found in untreated age-matched WKY (p less than 0.001). beta-Galactosidase specific activity on p-nitrophenyl-beta-D-galactoside was also decreased, 86% activity remaining relative to that found in untreated WKY (p less than 0.001). Glucosyl-galactosyl-hydroxylysyl glucohydrolase specific activity on glucosyl-galactosyl-hydroxylysine was equally diminished, 74% activity remaining relative to that found in untreated age-matched WKY (p less than 0.001). In contrast, the activities of two control glycosidases inactive on the carbohydrate moieties of basement membrane constituents, alpha-glucosidase assayed with p-nitrophenyl-alpha-D-glucoside as substrate and beta-glucosidase assayed with p-nitrophenyl-beta-D-glucoside as substrate, were significantly increased. All the alterations in enzyme activities observed in the kidney of SHR were also present in the long-term treated normotensive SHR. No effect of the hydralazine treatment on the three enzyme activities investigated could be demonstrated in the WKY. Thus the alterations observed in the kidneys of SHR appear to be independent of blood pressure level.
由于在自发性高血压中已报道存在伴有毛细血管基底膜增厚的肾微血管病,我们研究了12周龄自发性高血压大鼠(SHR)和年龄匹配的正常血压Wistar Kyoto大鼠(WKY)肾皮质中三种能够降解基底膜成分碳水化合物部分的溶酶体糖苷酶的活性。还测定了6至12周龄用肼苯哒嗪(平均剂量,每天18mg/kg,溶于饮用水中)处理的SHR和WKY的这些活性。未处理的SHR肾脏中,以唾液酸-α2-3-[3H]乳糖醇为底物的唾液酸酶比活性显著降低,相对于未处理的年龄匹配的WKY,活性仅保留40%(p<0.001)。以对硝基苯基-β-D-半乳糖苷为底物的β-半乳糖苷酶比活性也降低,相对于未处理的WKY,活性保留86%(p<0.001)。以葡萄糖基-半乳糖基-羟赖氨酰葡萄糖为底物的葡萄糖基-半乳糖基-羟赖氨酰葡萄糖水解酶比活性同样降低,相对于未处理的年龄匹配的WKY,活性保留74%(p<0.001)。相反,两种对基底膜成分碳水化合物部分无活性的对照糖苷酶的活性显著增加,一种是以对硝基苯基-α-D-葡萄糖苷为底物测定的α-葡萄糖苷酶,另一种是以对硝基苯基-β-D-葡萄糖苷为底物测定的β-葡萄糖苷酶。在SHR肾脏中观察到的所有酶活性改变在长期治疗的正常血压SHR中也存在。在WKY中未证明肼苯哒嗪治疗对所研究的三种酶活性有影响。因此,在SHR肾脏中观察到的改变似乎与血压水平无关。